We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
+10.53%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$608M
AUM Growth
-$455M
(-43%)
Cap. Flow
-$486M
Cap. Flow
% of AUM
-79.89%
Top 10 Holdings %
Top 10 Hldgs %
19.27%
Holding
429
New
65
Increased
103
Reduced
150
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Maximus
MMS
|
+$9M |
| 2 |
ESGR
Enstar Group
ESGR
|
+$3.12M |
| 3 |
Symbotic
SYM
|
+$2.62M |
| 4 |
Miller Industries
MLR
|
+$2.62M |
| 5 |
PagerDuty
PD
|
+$2.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Diamondback Energy
FANG
|
+$67.9M |
| 2 |
Ovintiv
OVV
|
+$64.5M |
| 3 |
ERF
Enerplus Corporation
ERF
|
+$61.9M |
| 4 |
SM Energy
SM
|
+$48.8M |
| 5 |
DEN
Denbury Inc.
DEN
|
+$33.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.7% |
| 2 | Technology | 16.95% |
| 3 | Industrials | 13.89% |
| 4 | Financials | 13.4% |
| 5 | Healthcare | 12.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VTYX
151
DELISTED
Ventyx Biosciences
VTYX
| $1.02M | 0.17% |
30,507
-3,093
| -9% | -$120K |
|
|
RXDX
152
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $1.01M | 0.17% |
9,455
+3,865
| +69% | +$445K |
|
153
Arcos Dorados Holdings
ARCO
$1.73B
| $1.01M | 0.17% |
131,119
-12,538
| -9% | -$103K |
|
154
Immunocore
IMCR
$1.78B
| $1.01M | 0.17% |
20,391
-1,010
| -5% | -$56.8K |
|
|
YTPG
155
DELISTED
TPG Pace Beneficial II Corp.
YTPG
| $995K | 0.16% |
99,758
| – | – |
|
156
Life Time Group Holdings
LTH
$9.42B
| $986K | 0.16% |
61,788
+46,776
| +312% | +$802K |
|
157
Chesapeake Utilities
CPK
$3.26B
| $977K | 0.16% |
7,636
-17
| -0.2% | -$2.11K |
|
|
BRD
158
DELISTED
Beard Energy Transition Acquisition Corp.
BRD
| $962K | 0.16% |
92,770
-6,280
| -6% | -$64.6K |
|
159
Xenon Pharmaceuticals
XENE
$6.32B
| $961K | 0.16% |
26,840
-5,891
| -18% | -$218K |
|
160
SoundThinking
SSTI
$107M
| $956K | 0.16% |
24,322
-4,272
| -15% | -$154K |
|
161
Mueller Industries
MLI
$14.1B
| $944K | 0.16% |
51,380
-14,088
| -22% | -$246K |
|
162
Leslie's
LESL
$11.6M
| $943K | 0.15% |
4,280
-1,232
| -22% | -$320K |
|
163
Standex International
SXI
$3.68B
| $940K | 0.15% |
+7,680
| New | +$874K |
|
164
TechTarget
TTGT
$246M
| $933K | 0.15% |
25,830
-305
| -1% | -$12.8K |
|
165
MGIC Investment
MTG
$6.27B
| $930K | 0.15% |
69,274
-1,098
| -2% | -$14.8K |
|
166
Danaos Corp
DAC
$2.55B
| $919K | 0.15% |
16,832
+268
| +2% | +$15.2K |
|
167
Cue Biopharma
CUE
$135M
| $918K | 0.15% |
8,574
| – | – |
|
168
LoveSac
LOVE
$239M
| $915K | 0.15% |
31,672
+10,975
| +53% | +$290K |
|
169
Build-A-Bear
BBW
$423M
| $911K | 0.15% |
39,206
+8,604
| +28% | +$200K |
|
170
Sterling Infrastructure
STRL
$20.3B
| $910K | 0.15% |
24,013
-2,576
| -10% | -$94K |
|
171
Lattice Semiconductor
LSCC
$17.6B
| $907K | 0.15% |
9,493
-3,362
| -26% | -$277K |
|
|
RYZ
172
Ryerson Holding Corp
RYZ
$1.6B
| $902K | 0.15% |
24,787
-156
| -0.6% | -$5.66K |
|
173
ConocoPhillips
COP
$147B
| $899K | 0.15% |
+9,059
| New | +$991K |
|
174
Aehr Test Systems
AEHR
$2.48B
| $896K | 0.15% |
28,880
+6,954
| +32% | +$224K |
|
175
Iron Mountain
IRM
$38.2B
| $894K | 0.15% |
16,901
| – | – |
|
Similar funds
VFG
SLG
KCP
UAG
PS
CICI
RPAM
BBI
Advisory Research's Q1 2023 Portfolio in Review
As of Q1 2023, Advisory Research held 429 positions worth $608M, down 43% from $1.06B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Advisory Research withdrew a net $486M in Q1 2023, closing 81 positions and reducing 150 holdings. Its most notable exit was Ovintiv, an estimated $64.5M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 8.6% a quarter earlier, followed by Technology and Industrials.
Against the trend, Advisory Research opened a new position in Maximus worth $9.19M.
- Advisory Research's largest Q1 2023 buy was Maximus: 116,828 shares worth $9.19M.
- Advisory Research added most to Enstar Group in Q1 2023, an estimated $3.12M increase.
- Advisory Research's biggest Q1 2023 reduction was Diamondback Energy, cutting an estimated $67.9M.
- Advisory Research fully exited Ovintiv in Q1 2023, selling an estimated $64.5M.
- Advisory Research's ten largest holdings make up 19% of its $608M portfolio in Q1 2023.
- Advisory Research opened 65 new positions and closed 81 in Q1 2023.
- Advisory Research's portfolio value fell 43% quarter-over-quarter to $608M.
Based on Advisory Research's 13F filing for Q1 2023, filed 12 May 2023.